Q2 2026
Read transcript →SP
ARS Pharmaceuticals, Inc. (SPRY) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$3.56
-4.96%
Mkt Cap $426.63M
Q1 2026
Read transcript →Q4 2025
Read transcript →Q3 2025
Read transcript →Q2 2025
Read transcript →Q1 2025
Read transcript →Q4 2024
Read transcript →Q3 2024
Read transcript →